Aleafia Health to Announce Fiscal Year 2023 Second Quarter Results
02 November 2022 - 11:55PM
Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“
Aleafia
Health” or the “
Company”) will announce
on November 9 prior to market open its fiscal year 2023 second
quarter results for the period ending September 30, 2022. The
Company will also host its earnings conference call the same day at
8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO
Matt Sale.
CONFERENCE CALL &
WEBCASTDate:
November 9, 2022Time: 8:30
a.m. ESTWebcast LinkPhone Registration
Link
This conference call will be webcast live over the internet and
can be accessed through the link provided above. Audio of the call
will be available to participants through both the conference call
line and webcast; however, the presentation may only be viewed via
the webcast. Participants who miss the live call can view a replay
at any time via the link provided.
For Investor & Media Relations:
Matthew Sale, CFOIR@AleafiaHealth.comLEARN MORE:
www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health, a vertically integrated and federally licensed
Canadian cannabis company, owns three licensed cannabis production
facilities, including the first large-scale, legal outdoor
cultivation facility in Canadian history, and operates a
strategically located distribution centre, all in the province of
Ontario. The Company produces a diverse portfolio of cannabis
derivative products including oils, capsules, edibles, sublingual
strips, and vapes, for sale in Canada in the adult-use and medical
markets and is pursuing opportunities in select international
jurisdictions. The Company owns and operates a virtual network of
medical cannabis clinics staffed by physicians and nurse
practitioners.
Forward Looking Information
This news release contains forward-looking information within
the meaning of applicable Canadian and United States securities
laws. Often, but not always, forward-looking information can be
identified by the use of words such as “plans”, “expects”,
“estimates”, “intends”, “anticipates”, or “believes” or variations
of such words and phrases or state that certain actions, events or
results “may”, “could”, “would”, “might” or “will” be taken, occur
or be achieved. Forward-looking information involves known and
unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of the Company or its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information, including
risks contained in the Company’s annual information form filed with
Canadian securities regulators available on the Company’s SEDAR
profile at www.sedar.com. Although the Company believes that the
assumptions and factors used in preparing the forward-looking
information in this news release are reasonable, undue reliance
should not be placed on such information and no assurance can be
given that such events will occur in the disclosed time frames or
at all. The forward-looking information included in this news
release are made as of the date of this news release and the
Company does not undertake any obligation to publicly update such
forward-looking information to reflect new information, subsequent
events or otherwise unless required by applicable securities
legislation.
Aleafia Health (TSX:AH.DB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Aleafia Health (TSX:AH.DB)
Historical Stock Chart
From Dec 2023 to Dec 2024